Plecanatide clinical trials
Also written Trulance.
How each study uses plecanatide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 19 Jan 2017 · TRULANCE · NDA 208745 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
14 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 13 · Other 1
Bausch Health Americas, Inc. (12) · University of Wisconsin, Madison (1) · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test plecanatide.
- Oct 2027This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FCPhase 2 · Bausch Health Americas, Inc.
Studies
Open first, then newest update. How each study uses plecanatide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 14
- This is a Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Efficacy and Safety of 2 Weight-based Treatment Groups of Plecanatide Versus Placebo in Children and Adolescent Participants 6 to Less Than 18 Years of Age With FCActive, not recruitingPhase 2Bausch Health Americas, Inc.NCT07723924Written as plecanatide
- The Plecanatide Irritable Bowel Syndrome With Constipation Safety and Efficacy Study (IBS-C)CompletedPhase 3Bausch Health Americas, Inc.NCT02387359Written as Plecanatide
- GCC Agonist Signal in the Small IntestineCompletedPhase 1University of Wisconsin, MadisonNCT05107219Written as Plecanatide
- Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)CompletedPhase 2Bausch Health Americas, Inc.NCT03596905Written as Plecanatide
- Efficacy and Safety of Plecanatide Comparing With Placebo in the Treatment of Functional ConstipationCompletedPhase 3Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.NCT05151328Written as Plecanatide
- Long Term Safety Study of PlecanatideCompletedPhase 3Bausch Health Americas, Inc.NCT02706483Written as Plecanatide
- SP-304 Dose Ranging Study in Patients With Chronic Idiopathic ConstipationCompletedPhase 2Bausch Health Americas, Inc.NCT01053962Written as SP-304 0.3 mg
- 12-Week Study of Plecanatide for CIC (The CIC3 Study)CompletedPhase 3Bausch Health Americas, Inc.NCT01982240Written as Plecanatide
- An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic ConstipationCompletedPhase 2Bausch Health Americas, Inc.NCT03120520Written as Plecanatide
- Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)CompletedPhase 3Bausch Health Americas, Inc.NCT01919697Written as Plecanatide
- Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)CompletedPhase 3Bausch Health Americas, Inc.NCT02493452Written as Plecanatide
- The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)CompletedPhase 2Bausch Health Americas, Inc.NCT01722318Written as Plecanatide
- The Plecanatide Chronic Idiopathic Constipation (CIC) StudyCompletedPhase 2/3Bausch Health Americas, Inc.NCT01429987Written as plecanatide
- 12-Week Study of Plecanatide for CIC (The National CIC3 Study)CompletedPhase 3Bausch Health Americas, Inc.NCT02122471Written as Plecanatide
Codes
What other systems call plecanatide · ClinicalTrials.gg INT006382
- MeSH (NLM) C584575plecanatideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7IK8Z952OKPLECANATIDEConfirmed FDA, NLM, Wikidata
- RxNorm 1873752Confirmed FDA, Wikidata
- Wikidata Q28559278plecanatideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C167027PlecanatideOne source FDA
- DrugBank DB13170One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C584575 | plecanatide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7IK8Z952OK | PLECANATIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1873752 | — | Confirmed FDA, Wikidata |
| Wikidata | Q28559278 | plecanatide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C167027 | Plecanatide | One source FDA |
| DrugBank | DB13170 | — | One source Wikidata |
Also registered as pirnabine (UNII S3FHL03F60).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.